{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fias-2021audio-recap-lkRQwP0a","width":444,"version":"1.0","type":"rich","title":"Key Studies Influencing My Practice Following IAS 2021—Audio Recap","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/86952976-b928-4317-884c-2c7ba3b2ae4d/1aef76aa-bfd7-4a51-952d-adda04f90947/ias-cf-podcasticon-recap.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/45904e81-a2f8-4114-ab05-c4140a6d7c4d\" height=\"200\" width=\"100%\" title=\"Key Studies Influencing My Practice Following IAS 2021—Audio Recap\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to expert insights from Babafemi Taiwo, MBBS, on updates from IAS 2021, including new data on COVID-19 and HIV, 2-drug ART, long-acting injectable ART, investigational agents, and new therapies for multidrug-resistant tuberculosis."}